Shtylla Brunilda
- SEC CIK
- 0001966915
No open-market purchases or sales filed in the past year.
Current role at each company
- STRO Sutro Biopharma, Inc.Chief Business Officeras of Aug 29, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shtylla Brunilda as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2023 (view filing) | Aug 28 | 1 day | Shtylla BrunildaChief Business Officer | SSale | −15.4K | $4.71 | −$72.7K | −100.0%0 after | |
| Aug 28, 2023 (view filing) | Aug 25 | 3 days | Shtylla BrunildaChief Business Officer | SSale | −11.6K | $4.59 | −$53.3K | −47.3%12.9K after |